Instruction for use: Anaprilin solution for injections 0,25%

Trade name of the drug – Anaprilin solution for injections 0,25%

Dosage Form: Injection

Active substance:Propranololum

ATX

C07AA05 Propranolol

Pharmacotherapeutic group: Beta-blockers

The nosological classification (ICD-10)

I10 Essential (primary) hypertension: hypertension; Arterial hypertension; Arterial hypertension crisis course; Essential Hypertension; Essential hypertension; Essential hypertension; Essential hypertension; Essential hypertension; Primary hypertension; Arterial hypertension, complications of diabetes; The sudden increase in blood pressure; Hypertensive disorders of blood circulation; hypertensive condition; hypertensive crises; arterial Hypertension; malignant Hypertension; Hypertonic disease; hypertensive crises; accelerated hypertension; malignant hypertension; The aggravation of hypertensive disease; Transient hypertension; Isolated systolic hypertension

I15 Secondary hypertension: Arterial hypertension, complications of diabetes; hypertension; The sudden increase in blood pressure; Hypertensive disorders of blood circulation; hypertensive condition; hypertensive crises; hypertension; arterial Hypertension; malignant Hypertension; hypertensive crises; accelerated hypertension; malignant hypertension; The aggravation of hypertensive disease; Transient hypertension; hypertension; Arterial hypertension; Arterial hypertension crisis course; renovascular hypertension; Hypertension symptomatic; Renal hypertension; Renovascular hypertension; renovascular hypertension; Symptomatic hypertension

I20 Angina [angina]: Heberden disease; Angina pectoris; The attack of angina pectoris; recurrent angina; Spontaneous angina; Stable angina pectoris; Angina rest; Angina progressing; Angina mixed; Angina spontaneous; stable angina; Chronic stable angina; Angina Syndrome X

I49.9 Irregular heartbeat, unspecified: Paroxysmal supraventricular tachycardia; extrasystole arrhythmia; Atrial fibrillation tachysystolic; supraventricular tachyarrhythmia; supraventricular arrhythmias; AV reciprocating tachycardia; AV-nodal reciprocating tachycardia; ventricular fibrillation; Irregular heartbeat; Antidromic reciprocating tachycardia; Cardiac arrhythmias; Arrhythmias; Arrhythmia; Heart arythmy; Arrhythmia due to hypokalemia; ventricular tachyarrhythmias; The high frequency of ventricular contraction; Cardiac arrhythmias; Paroxysmal supraventricular arrhythmia; Paroxysmal supraventricular arrhythmia; Paroxysmal dysrhythmia; Paroxysmal atrial-ventricular rhythm; cardiac arrhythmias; supraventricular tachycardia; tachyarrhythmia; Precordial abnormal pulsation

O62.2 Other uterine inertia: metroparalysis; The weakness of labor activity; Decreased uterine tone; Induction of labor; Induction of labor at term; Induction of labor at term or near term; Activation of labor

R07.2 Pain in the heart: neuroses of the heart; Myocardial ischemic pain; Pain syndrome in myocardial infarction; cardialgia; cardioneurosis; Cardiac syndrome; Pain in cardiac patients; Cardialgia on background dyshormonal myocardial dystrophy; Functional cardialgia; Psevdostenokardiya; pericardial pain

Composition (per tablet):

1 USD 1 ml injection solution contains 2.5 mg of propranolol hydrochloride, in multiples of 10 pcs.

Pharmacological Properties of Anaprilin solution for injections 0,25%

Pharmachologic effect - antianginal, hypotensive, antiarrhythmic, uterotoniziruyuschee.

Beta-adrenoceptor blocking.

Indications of Anaprilin solution for injections 0,25%

Angina pectoris, arrhythmias, hypertension, primary uterine inertia.

Contraindications

AV block, asthma, bronchospastic syndrome, congestive heart failure, pregnancy, diabetes with ketoacidosis.

Side effect

Dizziness, weakness, indigestion, bronchospasm, pruritus.

Interaction

Incompatible with neuroleptics and tranquilizers.

Dosage and Administration

intravenous drip administered (500 ml of 5% glucose solution). When paroxysmal cardiac arrhythmias and thyrotoxic crisis - at an initial dose of 1 mg, then 2 min administered the same dose again. In the absence of effect on / in the introduction is repeated until the maximum dose of 10 mg (patients under anesthesia is not more than 5 mg), under the control of blood pressure and ECG.

Storage conditions of Anaprilin solution for injections 0,25%

In a dry, dark place.

Keep out of the reach of children.

Shelf life

3 years.

Do not use beyond the expiration date printed on the package.